S-1/A: Reborn Coffee Files Amendment for Resale of 3.17 Million Shares

Reborn Coffee is registering for resale up to 3,172,948 shares of its common stock by selling securityholders, including shares issuable under a Standby Equity Purchase Agreement (SEPA) and convertible notes.

Summary

• Reborn Coffee has filed an amendment to its Form S-1 registration statement with the SEC.
• The filing pertains to the potential resale of up to 3,172,948 shares of the company's common stock.
• These shares are held by selling securityholders, including YA II PN, LTD, Lisa Lee, Charles Chang Woo Jeong, James Chae, Quen Inno Tech Co. Ltd., and Scott Lee.
• The shares include those issued or potentially issued under a Standby Equity Purchase Agreement (SEPA) with YA II PN, convertible promissory notes, and private placements.
• Reborn Coffee will not receive any proceeds from the sale of these shares by the selling stockholders, except for potential proceeds from the exercise of warrants.
• The company intends to use any proceeds from YA II PN under the SEPA and the Warrant exercises for working capital, strategic and general corporate purposes.
• The company's common stock is listed on Nasdaq under the symbol REBN, and the last reported closing price on September 26, 2024, was $3.02 per share.
• As of September 26, 2024, there were 3,509,754 shares of Common Stock outstanding.
• If all shares being registered hereby were sold, it would comprise approximately 47.5% of our total shares of Common Stock outstanding.

Sentiment

Score: 4

Explanation: The document is largely neutral, presenting facts about a stock resale and potential capital raising. However, the potential for significant dilution and the lack of direct proceeds to the company (except from warrant exercises) temper any positive sentiment.

Positives

• The company has access to potential funding through the SEPA with YA II PN, up to $5,000,000.
• The company may receive proceeds from the cash exercise of the Warrant, which, if fully exercised in cash at the current exercise price with respect to the Warrant, would result in gross proceeds to us of approximately $400,750.
• The company intends to use any proceeds from YA II PN that we receive under the SEPA or the Warrant for working capital, strategic and general corporate purposes.

Negatives

• The company will not receive any proceeds from the resale of shares by the selling stockholders.
• The issuance of shares to the Selling Stockholders may cause substantial dilution to our existing shareholders and the sale of such shares acquired by the Selling Stockholders could cause the price of our Common Stock to decline.
• If all shares being registered hereby were sold, it would comprise approximately 47.5% of our total shares of Common Stock outstanding.

Risks

• The actual number of shares sold under the SEPA and the resulting gross proceeds are uncertain and depend on various factors, including market conditions and the trading price of the common stock.
• The issuance of common stock to the selling stockholders may cause substantial dilution to existing shareholders, and the sale of these shares could cause the stock price to decline.
• The company may require additional financing to sustain operations, and the failure to obtain sufficient funding could have a material adverse effect on the business.
• The company's management has broad discretion over the use of proceeds from the sale of shares to YA II PN, and the proceeds may not be invested successfully.
• The terms of our indebtedness, including the covenants and the dates on which principal and interest payments on our indebtedness are due, increases the risk that we will be unable to continue as a going concern.
• If the company is unable to satisfy the applicable continued listing requirements of Nasdaq, our common stock could be delisted.
• Because the currently outstanding shares of Common Stock that are being registered in this prospectus represent a substantial percentage of our outstanding Common Stock, the sale of such securities could cause the market price of our Common Stock to decline significantly.

Future Outlook

The company intends to use any proceeds from YA II PN that we receive under the SEPA or the Warrant for working capital, strategic and general corporate purposes. The company may sell shares under the SEPA, and the net proceeds will depend on the frequency and prices at which we sell shares of Common Stock to YA II PN.

Industry Context

This announcement reflects a company seeking capital and providing liquidity for existing investors, a common practice in the current market environment, particularly for smaller reporting companies.

Comparison to Industry Standards

• The use of Standby Equity Purchase Agreements (SEPAs) is a relatively common financing mechanism for small-cap companies, offering flexibility in raising capital as needed.
• However, SEPAs can also lead to significant dilution for existing shareholders if the company's stock price declines.
• Comparable companies that have utilized similar financing structures include those in the biotechnology and technology sectors, where access to capital is crucial for ongoing operations and development.
• The potential dilution of approximately 47.5% of the total shares of Common Stock outstanding is significant and could be viewed negatively by investors.

Stakeholder Impact

• Existing shareholders may experience dilution of their ownership interests.
• The market price of the company's common stock could be negatively impacted by the resale of a large number of shares.
• The company's access to capital markets could be affected by the potential dilution and market volatility.

Next Steps

• The SEC must declare the registration statement effective before the selling stockholders can offer the shares for resale.
• The company may elect to sell shares to YA II PN under the SEPA, depending on market conditions and its funding needs.
• The selling stockholders may sell their shares from time to time, depending on market conditions and their investment strategies.

Key Dates

Keywords

resale, common stock, SEPA, YA II PN, convertible notes, private placements, registration statement, dilution, warrant, selling stockholders